Clinical Trial Update: Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

View source ↗

Summary

An ongoing clinical study sponsored by the Cancer Institute and Hospital, Chinese Academy of Medical Sciences, evaluating AI-assisted HER2 expression assessment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Urothelial Carcinoma (UC), HER2 | Status: ENROLLING_BY_INVITATION